New interventions for combating obesity among African American women are starting by addressing barriers to traditional exercise programs.

Dr Jeff Mechanick discusses how a decade of advances has changed the context in which bariatric surgeries are performed.

Researchers have identified three stages in type 1 diabetes, and interventions can help stall progression of the disease.

The just-published ELITE trial suggests that coronary risk should not be a justification to deny hormone therapy to appropriate candidates in early menopause.

New preclinical data show that ghrelin may play an important role in food behaviors and that blocking these receptors may reduce food foraging, hoarding, and intake.

Dr Peter Yellowlees comments on research that finally settles the question of whether statin use lowers the incidence of dementia.

Dr Thomas Allison sits down with Dr Francisco Lopez-Jimenez and Dr Steven Kopecky to talk about the use of LDL-C goals, and their approach to cholesterol management following the IMPROVE-IT trial.

Eric Topol interviews Donna Spruijt-Metz on how mobile sensors can be used to both understand childhood obesity and change eating behavior.

Dr Amy Pollak talks to Dr William Haley of the Mayo Clinic about how to interpret the results from the SPRINT trial and why practitioners should stay tuned for further results.

'Whatever it takes,' says Dr Jeffrey Berns, we need to get patients with advanced kidney disease into the care of a nephrologist before dialysis is initiated to reduce mortality during the first year.